C-APS

T:APS - APTOSE BIOSCIENCES INC. - http://aptose.com/

20:38:33 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
APS - T	0.5	1.63	·	1.68	0.2	1.63	-0.02	-1.2	5.8	8	37	1.68 1.69 1.61	10.35 1.58	16:00:00	May 14	15 min RT 2¢
TSX - T	0.5	1.63	·	1.68	0.2	1.63	-0.02	-1.2	3.7	5	14	1.68 1.69 1.61	10.35 1.58	16:00:00		15 min
NEO ATS - U						1.69	+0.04	2.4	0.3	0	3	1.63 1.69 1.63		13:45:07		15 min
Alpha - A						1.64	-0.01	-0.6	0.7	1	4	1.68 1.69 1.64		13:35:41		15 min
Pure - P						1.65			0.2	0	2			Apr 29		15 min
Chi-X - X						1.61	-0.04	-2.4	0.6	1	2	1.61 1.61 1.61		14:43:54		15 min
CX2 - H						1.65			0.001		1			May 13		15 min
CXD - D						1.65			0.1	0	4			May 14		15 min
TriAct - M						1.65			0.09	0	6			Sep 11-20		15 min
CS2 - S						1.69	+0.04	2.4	0.1	0	1	1.69 1.69 1.69		13:45:07		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - Last 10 of 37

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
16:00:00	T	1.63	-0.02	100	79 CIBC	1 Anonymous	KQ
15:56:52	T	1.68	0.03	100	80 National Bank	79 CIBC	K
15:16:18	M	1.68	0.03	60	80 National Bank	80 National Bank	E
15:04:29	H	1.61	-0.04	1	2 RBC	80 National Bank	E
15:03:13	M	1.68	0.03	1	80 National Bank	80 National Bank	E
14:43:54	D	1.65		59	7 TD Sec	2 RBC	E
14:43:54	T	1.63	-0.02	800	7 TD Sec	80 National Bank	K
14:43:54	T	1.63	-0.02	100	7 TD Sec	79 CIBC	K
14:43:54	X	1.61	-0.04	200	7 TD Sec	1 Anonymous	K
14:43:53	X	1.61	-0.04	400	79 CIBC	1 Anonymous	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2024-05-14 20:06	C:APS	1.65	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-05-14 20:00	C:APS	1.65	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-05-14 16:11	C:APS	1.65	News Release200	Aptose Biosciences spends $6.44M on R&D in Q1 2024
2024-05-06 16:53	C:APS	1.69	News Release200	Aptose Biosciences to release Q1 2024 results May 14
2024-03-26 18:23	C:APS	2.13	SEDAR Annual Report803	SEDAR Annual Report
2024-03-26 18:16	C:APS	2.13	SEDAR MD & A815	SEDAR MD & A
2024-03-26 18:03	C:APS	2.13	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-03-26 16:26	C:APS	2.13	News Release200	Aptose Biosciences spends $33.27M on R&D in 2023
2024-03-18 16:43	C:APS	2.00	News Release200	Aptose to release 2023 results, host call March 26
2024-01-31 16:10	C:APS	2.63	News Release200	Aptose closes financings for $13.7-million (U.S.)
2024-01-26 10:25	C:APS	2.64	News Release200	Aptose prices offering at $1.71 (U.S.) per share
2023-12-11 01:17	C:APS	3.80	News Release200	Aptose releases tuspetinib data from phase 1/2 study
2023-11-30 17:13	C:APS	3.32	News Release200	Aptose Biosciences adds executive duties to Payne
2023-11-09 18:39	C:APS	4.27	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-11-09 18:30	C:APS	4.27	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-11-09 16:09	C:APS	4.27	News Release200	Aptose spends $8.25-million on R&D in Q3
2023-10-30 11:47	C:APS	3.80	News Release200	Aptose talks Aptivate study results, ESH conference
2023-10-26 11:51	C:APS	3.49	News Release200	Aptose to release Q3 2023 results Nov. 9
2023-10-23 12:50	C:APS	3.20	News Release200	Aptose to provide clinical update at ESH conference
2023-09-06 14:09	C:APS	5.59	News Release200	Aptose Biosciences closes $3M investment by Hanmi